BRCA2 mutations predispose carriers to breast and ovarian cancer and can also cause other cancers and Fanconi anemia. BR...
...Brca2, Mnd1, FancG) and in the meiotic checkpoint (cyclin B2, Cks2), but does not affect genes encoding protein componen...
...BRCA2 germ-line mutations. Breast conservative surgery with chemio-radiotherapy is the most commonly used treatment brea...
...BRCA2 point mutations, gathered from four National Institutions. We report the identification of BRCA1 genomic rearrange...
...BRCA2-related breast cancer. Ovarian cancers due to BRCA1 or BRCA2 mutations cannot usually be distinguished from their ...
...BRCA2 genes. Questionnaires, asking respondents to rank their preferences for functions, or attributes, of genetic couns...
...BRCA2 mutations have been identified. Diagnostic procedures for male breast lesions should be the same as for the female...
...BRCA2 mutation carriers and 24 non-BRCA mutation carriers).,The prevalence of high-risk lesions is equal in women with a...
...BRCA2, and CHEK2) whose products are involved in the DNA damage-signaling pathway have been implicated in prostate cance...
...BRCA2 mutations. An additional four invasive cancers from carriers of a pathogenic BRCA1 mutation in the context of a fa...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
